.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Uni-leaflet mitral valve (ULMV) represents an exceptionally rare congenital cardiac anomaly. Historically, clinicians considered this condition incompatible with long-term survival. However, recent advances in diagnostic imaging have led to more frequent identifications in adult patients. A systematic review of adult cases highlights that this condition demonstrates significant clinical and anatomical diversity. Understanding these variations is essential for providing effective care to affected individuals.
Most adults with this anomaly present with symptoms like dyspnea or heart failure. Research shows that posterior leaflet hypoplasia or agenesis occurs in approximately 97.5% of cases. Consequently, over half of these patients suffer from moderate or greater mitral regurgitation. Furthermore, comorbid conditions such as atrial fibrillation and atrial septal defects are common. Physicians must carefully evaluate these associated anomalies to optimize patient outcomes.
Transthoracic echocardiography serves as the universal tool for initial diagnosis. Meanwhile, transesophageal and three-dimensional imaging offer incremental details regarding the valve's unique anatomy. Regarding treatment, approximately one-third of adult patients require surgical intervention. This typically involves either mitral valve repair or replacement. Fortunately, outcomes for these interventions are generally favorable when tailored to the specific anatomical spectrum of the patient.
The clinical heterogeneity of ULMV suggests it represents a developmental spectrum rather than a single fixed entity. Therefore, experts emphasize the need for standardized definitions across the medical community. Prospective registries will also play a vital role in improving risk stratification. Such data will eventually guide clinicians in refining management protocols for this rare but significant valve disorder.
Most symptomatic adults experience dyspnea, palpitations, or signs of heart failure. These symptoms often stem from significant mitral regurgitation or associated arrhythmias like atrial fibrillation.
Diagnosis begins with transthoracic echocardiography to assess valve structure. However, specialists often use 3D transesophageal echocardiography to obtain precise anatomical details necessary for planning surgical interventions.
Not necessarily. While about one-third of patients undergo valve repair or replacement, others may be managed conservatively. The decision depends on the severity of regurgitation and the presence of symptoms.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review characterizing the clinical presentation, anatomy, and management of adult patients with rare uni-leaflet mitral valve (ULMV) anomaly....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
